REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr. Morepen Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Dr. Morepen Limited Profile Updated: November 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Dr. Morepen Limited is an unlisted company, incorporated on 11/07/2001. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U24232DL2001PLC111636 and registration number is 111636.

Legal Address
409, Antriksh Bhawan 22, K.G. Marg
Central Delhi; Delhi; Postal Code: 110001

Contact Details: Purchase the Dr. Morepen Limited report to view the information.

Basic Information
Total Employees:
Purchase the Dr. Morepen Limited report to view the information.
Outstanding Shares:
Purchase the Dr. Morepen Limited report to view the information.
Registered Capital:
Purchase the Dr. Morepen Limited report to view the information.
Financial Auditors:
Purchase the Dr. Morepen Limited report to view the information.
Incorporation Date:
July 11, 2001
Key Executives
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Total Care Limited
95%
Company Performance
Financial values in the chart are available after Dr. Morepen Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-4.8%
Total operating revenue
-3.02%
Operating profit (EBIT)
-34.29%
EBITDA
-15.41%
Net Profit (Loss) for the Period
-32.98%
Total assets
-20.32%
Total equity
-29.8%
Operating Profit Margin (ROS)
-2.74%
Net Profit Margin
-2.67%
Return on Equity (ROE)
-19.84%
Quick Ratio
0.11%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?